Congestive heart failure in renal transplant recipients

Risk factors, outcomes, and relationship with ischemic heart disease

Claudio Rigatto, Patrick Parfrey, Robert Foley, Carol Negrijn, Carrie Tribula, John Jeffery

Research output: Contribution to journalArticle

198 Citations (Scopus)

Abstract

Cardiovascular disease (CVD) is the major cause of death in renal transplant recipients (RTR). Several cohort studies have examined CVD in RTR, but none have addressed the development of congestive heart failure (CHF). CHF would hypothetically be a frequent and prognostically important event in RTR. A retrolective cohort study was, therefore, conducted in two Canadian centers to describe the incidence, risk factors for, and interrelationships between de novo CHF, de novo ischemic heart disease (IHD), and mortality in 638 consecutive adult RTR who were free of cardiac disease at 1 yr posttransplant. Detailed clinic and hospital records were available for 99% of patients. Median follow-up was 7 yr (range, 1 to 28 yr). De novo CHF occurred as frequently as de novo IHD (1.26 versus 1.22 events/100 patient-years, respectively) and appeared to carry a similar prognosis (relative risk for death, 1.78 [confidence interval, 1.21 to 2.61] for CHF versus 1.50 [1.05 to 2.13] for IHD). The incidence of CHF was considerably higher than that in the Framingham cohort, whereas the incidence of IHD was not, suggesting that renal transplantation might correspond more to a state of "accelerated heart failure" than to "accelerated atherosclerosis." Age, diabetes, gender, BP, and anemia were identified as independent risk factors for de novo CHF, whereas age, diabetes, gender, BP, and rejection were independent risk factors for de novo IHD. Optimal strategies for treatment of BP and anemia in RTR will need to be determined in randomized controlled trials.

Original languageEnglish (US)
Pages (from-to)1084-1090
Number of pages7
JournalJournal of the American Society of Nephrology
Volume13
Issue number4
StatePublished - Apr 15 2002

Fingerprint

Myocardial Ischemia
Heart Failure
Kidney
Anemia
Incidence
Cohort Studies
Cardiovascular Diseases
Transplant Recipients
Hospital Records
Kidney Transplantation
Cause of Death
Heart Diseases
Atherosclerosis
Randomized Controlled Trials
Confidence Intervals
Mortality

Cite this

Congestive heart failure in renal transplant recipients : Risk factors, outcomes, and relationship with ischemic heart disease. / Rigatto, Claudio; Parfrey, Patrick; Foley, Robert; Negrijn, Carol; Tribula, Carrie; Jeffery, John.

In: Journal of the American Society of Nephrology, Vol. 13, No. 4, 15.04.2002, p. 1084-1090.

Research output: Contribution to journalArticle

Rigatto, Claudio ; Parfrey, Patrick ; Foley, Robert ; Negrijn, Carol ; Tribula, Carrie ; Jeffery, John. / Congestive heart failure in renal transplant recipients : Risk factors, outcomes, and relationship with ischemic heart disease. In: Journal of the American Society of Nephrology. 2002 ; Vol. 13, No. 4. pp. 1084-1090.
@article{05c9b9f63e2644869d1ad0f7e0086674,
title = "Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease",
abstract = "Cardiovascular disease (CVD) is the major cause of death in renal transplant recipients (RTR). Several cohort studies have examined CVD in RTR, but none have addressed the development of congestive heart failure (CHF). CHF would hypothetically be a frequent and prognostically important event in RTR. A retrolective cohort study was, therefore, conducted in two Canadian centers to describe the incidence, risk factors for, and interrelationships between de novo CHF, de novo ischemic heart disease (IHD), and mortality in 638 consecutive adult RTR who were free of cardiac disease at 1 yr posttransplant. Detailed clinic and hospital records were available for 99{\%} of patients. Median follow-up was 7 yr (range, 1 to 28 yr). De novo CHF occurred as frequently as de novo IHD (1.26 versus 1.22 events/100 patient-years, respectively) and appeared to carry a similar prognosis (relative risk for death, 1.78 [confidence interval, 1.21 to 2.61] for CHF versus 1.50 [1.05 to 2.13] for IHD). The incidence of CHF was considerably higher than that in the Framingham cohort, whereas the incidence of IHD was not, suggesting that renal transplantation might correspond more to a state of {"}accelerated heart failure{"} than to {"}accelerated atherosclerosis.{"} Age, diabetes, gender, BP, and anemia were identified as independent risk factors for de novo CHF, whereas age, diabetes, gender, BP, and rejection were independent risk factors for de novo IHD. Optimal strategies for treatment of BP and anemia in RTR will need to be determined in randomized controlled trials.",
author = "Claudio Rigatto and Patrick Parfrey and Robert Foley and Carol Negrijn and Carrie Tribula and John Jeffery",
year = "2002",
month = "4",
day = "15",
language = "English (US)",
volume = "13",
pages = "1084--1090",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "4",

}

TY - JOUR

T1 - Congestive heart failure in renal transplant recipients

T2 - Risk factors, outcomes, and relationship with ischemic heart disease

AU - Rigatto, Claudio

AU - Parfrey, Patrick

AU - Foley, Robert

AU - Negrijn, Carol

AU - Tribula, Carrie

AU - Jeffery, John

PY - 2002/4/15

Y1 - 2002/4/15

N2 - Cardiovascular disease (CVD) is the major cause of death in renal transplant recipients (RTR). Several cohort studies have examined CVD in RTR, but none have addressed the development of congestive heart failure (CHF). CHF would hypothetically be a frequent and prognostically important event in RTR. A retrolective cohort study was, therefore, conducted in two Canadian centers to describe the incidence, risk factors for, and interrelationships between de novo CHF, de novo ischemic heart disease (IHD), and mortality in 638 consecutive adult RTR who were free of cardiac disease at 1 yr posttransplant. Detailed clinic and hospital records were available for 99% of patients. Median follow-up was 7 yr (range, 1 to 28 yr). De novo CHF occurred as frequently as de novo IHD (1.26 versus 1.22 events/100 patient-years, respectively) and appeared to carry a similar prognosis (relative risk for death, 1.78 [confidence interval, 1.21 to 2.61] for CHF versus 1.50 [1.05 to 2.13] for IHD). The incidence of CHF was considerably higher than that in the Framingham cohort, whereas the incidence of IHD was not, suggesting that renal transplantation might correspond more to a state of "accelerated heart failure" than to "accelerated atherosclerosis." Age, diabetes, gender, BP, and anemia were identified as independent risk factors for de novo CHF, whereas age, diabetes, gender, BP, and rejection were independent risk factors for de novo IHD. Optimal strategies for treatment of BP and anemia in RTR will need to be determined in randomized controlled trials.

AB - Cardiovascular disease (CVD) is the major cause of death in renal transplant recipients (RTR). Several cohort studies have examined CVD in RTR, but none have addressed the development of congestive heart failure (CHF). CHF would hypothetically be a frequent and prognostically important event in RTR. A retrolective cohort study was, therefore, conducted in two Canadian centers to describe the incidence, risk factors for, and interrelationships between de novo CHF, de novo ischemic heart disease (IHD), and mortality in 638 consecutive adult RTR who were free of cardiac disease at 1 yr posttransplant. Detailed clinic and hospital records were available for 99% of patients. Median follow-up was 7 yr (range, 1 to 28 yr). De novo CHF occurred as frequently as de novo IHD (1.26 versus 1.22 events/100 patient-years, respectively) and appeared to carry a similar prognosis (relative risk for death, 1.78 [confidence interval, 1.21 to 2.61] for CHF versus 1.50 [1.05 to 2.13] for IHD). The incidence of CHF was considerably higher than that in the Framingham cohort, whereas the incidence of IHD was not, suggesting that renal transplantation might correspond more to a state of "accelerated heart failure" than to "accelerated atherosclerosis." Age, diabetes, gender, BP, and anemia were identified as independent risk factors for de novo CHF, whereas age, diabetes, gender, BP, and rejection were independent risk factors for de novo IHD. Optimal strategies for treatment of BP and anemia in RTR will need to be determined in randomized controlled trials.

UR - http://www.scopus.com/inward/record.url?scp=0036209854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036209854&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 1084

EP - 1090

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 4

ER -